Skip to main content
Equibles
ONC logo

ONC · BeOne Medicines Ltd. · Held by Funds

Track ONC — free

Use ONC with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research ONC.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$416.54 +0.58 (+0.14%) At close · Nov 13 Play latest call Q2 2026 earnings call transcript
Rebalance outlook locked
Market Cap
$47.58B
Shares
114.23M
Volume · Nov 13 345.46K Avg daily vol (3M) 404.68K

Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this exact listed security, matched by CUSIP. Each row is one fund position with its size, value and weight in that fund.

Fund Ownership of ONC by Fund Type

Registered funds' Form N-PORT reports for the quarter ended Jun 30, 2026

Index funds and index ETFs hold 0.78% of shares outstanding.

Fund type Of shares outstanding Shares
Index funds 0.02% 25,154
Index ETFs 0.76% 868,596
Active ETFs 0.15% 166,077
Active funds 7.68% 8,775,088
Unclassified 0.02% 18,915
All registered funds 8.63% 9,853,830
How fund types are measured

Each fund series counts once, with its latest Form N-PORT report dated inside the quarter; only long share positions count, restated to today's split basis. The fund type is the series' latest Form N-CEN answer on or before the quarter end (the index-fund box and the exchange-traded flag), never its name. Unclassified funds have no usable N-CEN; unit investment trusts are among them, so index ownership is a floor. Funds sit inside their advisers' 13F reports, so these shares overlap the 13F figures and are never added to them.

Funds holding ONC

140 fund positions
Fund Balance Value % of Fund Open
New Perspective Fund 2,663,960 $759,148,681 0.45%
New Economy Fund 875,269 $314,729,227 0.63%
Fidelity Growth Company Fund 624,125 $224,422,868 0.23%
New World Fund Inc 677,287 $214,029,465 0.24%
PRIMECAP Odyssey Aggressive Growth Fund 646,087 $204,169,953 2.76%
EUPAC Fund 700,821 $199,712,960 0.14%
PRIMECAP Odyssey Growth Fund 585,087 $184,893,343 3.05%
iShares Biotechnology ETF 564,180 $160,774,375 1.77%
American Funds Global Insight Fund 374,007 $118,189,952 0.55%
T. Rowe Price International Stock Fund 261,437 $82,616,706 0.62%
First Trust NYSE Arca Biotechnology Index Fund 245,095 $69,844,722 2.48%
Fidelity Growth Company K6 Fund 175,630 $63,153,035 0.22%
Baird Chautauqua International Growth Fund 179,205 $51,068,049 3.91%
Fidelity Series Growth Company Fund 141,939 $51,038,426 0.21%
Fidelity Series Emerging Markets Opportunities Fund 139,674 $44,138,381 0.14%
Capital Group Global Growth Equity ETF 106,725 $38,376,176 0.32%
PGIM Jennison Health Sciences Fund 95,362 $34,290,268 2.29%
College Retirement Equities Fund - Global Equities Account 118,700 $33,825,939 0.09%
Select Health Care Portfolio 90,000 $32,362,200 0.48%
Fidelity Contrafund 105,196 $29,977,704 0.02%
Global Growth Fund 101,482 $28,919,326 0.27%
College Retirement Equities Fund - Total Global Stock Account 78,700 $22,427,139 0.02%
Capital Group Global Equity ETF 59,100 $21,251,178 0.68%
Artisan International Small-Mid Fund 71,843 $20,473,100 0.81%
Fidelity Advisor Health Care Fund 46,000 $14,536,460 0.47%
Capital Group International Equity ETF 40,021 $14,390,751 0.58%
Franklin Dynatech Fund 50,000 $14,248,500 0.05%
Baird Chautauqua Global Growth Fund 45,756 $13,039,087 2.91%
VIP Contrafund Portfolio 40,672 $11,590,300 0.04%
VanEck Biotech ETF 38,996 $11,112,690 2.81%
EUPAC Fund 37,991 $10,826,295 0.14%
Franklin Biotechnology Discovery Fund 33,421 $10,561,370 0.92%
Fidelity Advisor New Insights Fund 34,240 $9,757,373 0.03%
New World Fund 33,658 $9,591,520 0.21%
Select Biotechnology Portfolio 26,098 $9,384,319 0.15%
American Funds International Vantage Fund 27,797 $8,784,130 0.33%
Capital Group New Geography Equity ETF 22,791 $8,195,188 0.27%
Fidelity Nasdaq Composite Index Fund 21,295 $7,657,256 0.03%
Tema Oncology ETF 18,669 $6,712,999 3.18%
Fidelity Contrafund K6 23,082 $6,577,678 0.02%
American Funds Developing World Growth & Income Fund 17,082 $6,142,346 0.23%
Empower Emerging Markets Equity Fund 20,565 $5,860,408 0.30%
T. Rowe Price Diversified Mid-Cap Growth Fund, Inc. 19,915 $5,675,178 0.12%
PACE International Equity Investments 16,783 $5,303,596 0.71%
Emerging Markets Equities Fund Inc 18,454 $5,258,836 0.97%
Fidelity Series Opportunistic Insights Fund 15,629 $4,453,796 0.03%
VIP Health Care Portfolio 15,000 $4,274,550 0.37%
Lazard Emerging Markets Equity Advantage Portfolio 14,720 $4,194,758 0.46%
Nomura Focused Emerging Markets Equity ETF 14,328 $4,083,050 0.61%
Avantis Emerging Markets Equity ETF 11,267 $4,051,388 0.01%
Showing 1–50 of 140 positions
Key facts CIK 1651308 CUSIP 07725L102 13F (30d) 269 filings 245 filers Visit website Investor relations